WHO ICTRP trial
A Comparison of Remifentanil Patient-Controlled Analgesia vs. Oral Morphine…
EUCTR2008-007322-19-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2008-007322-19-GB |
|---|---|
| Public title | A Comparison of Remifentanil Patient-Controlled Analgesia vs. Oral Morphine Analgesia for Dressing Changes in Burns Patients. |
| Scientific title | A Comparison of Remifentanil Patient-Controlled Analgesia vs. Oral Morphine Analgesia for Dressing Changes in Burns Patients. |
| Primary sponsor | Queen Victoria Hospital NHS Foundation Trust |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | United Kingdom |
| Conditions | Pain experienced by patients with pre-existing burns presenting to the burns outpatients unit requiring two or more dressing changes |
| Interventions | Trade Name: Remifentanil Product Name: Remifentanil Pharmaceutical Form: Powder for solution for infusion Trade Name: Oramorph Product Name: Oramorph Pharmaceutical Form: Oral solution |
| Registration date | Nov 23, 2010 |
| Target size | 58 |
| Secondary IDs | RPC190 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: